Overview
>Biotechnology and Competitive Advantage investigates the development of biotechnology in Europe and the United States. It examines why Europe has fallen behind in applying biotechnology, when its scientific capabilities are largely comparable to those in the US. In addition it sheds new light on the wider context of the theory of growth of new technologies.This innovative book brings together a wide range of material concerning socio-economic aspects of the development of biotechnology in Europe and the US. Issues discussed include: European policy for biotechnology, in individual countries and at the European Union level risk regulation and the ways in which industry, regulators and non-government organizations manage risk regulation and the perception of risk the formation and roles of biotechnology firms in Europe and the US and their relative capabilities gene therapy development in Europe and the US the impact on Europe of overseas biotechnology research by European multinationals. This book argues in favour of developing an integrated research and development system which will strengthen the research and development capabilities of all the actors involved. This book will be of great interest to science policymakers; businesses and academics studying the development of biotechnology and students of economics and business studies throughout Europe and the US.
Full Product Details
Author: Jacqueline Senker
Publisher: Edward Elgar Publishing Ltd
Imprint: Edward Elgar Publishing Ltd
Dimensions:
Width: 15.60cm
, Height: 1.90cm
, Length: 23.40cm
Weight: 0.430kg
ISBN: 9781858987392
ISBN 10: 1858987393
Pages: 192
Publication Date: 26 March 1998
Audience:
College/higher education
,
Undergraduate
,
Postgraduate, Research & Scholarly
Format: Hardback
Publisher's Status: Active
Availability: To order
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.
Reviews
'I found that this volume presented a good many facts and some interesting analyses of the biotechnology industries of Europe and America . . . I suspect that policymakers and business managers will also find the factual base and discussions in this volume to be a catalyst for clearer thinking about a number of issues which confront them.' -- John W. Medcof, R&D Management 'Based on a broad theoretical foundation and broad empirical evidence gathered with different methodologies and tools, it provides many insights into the state of biotechnology in Europe and many suggestions for political measures. Viewed as a whole, this book is rewarding reading for researchers, management practitioners and policymakers.' -- Andre Jungmittag, Research Policy 'The book gives lots of interesting information on venture capital biotechnology companies. . .' -- Parvinder Chawla, Journal of Scientific and Industrial Research
'I found that this volume presented a good many facts and some interesting analyses of the biotechnology industries of Europe and America ... I suspect that policymakers and business managers will also find the factual base and discussions in this volume to be a catalyst for clearer thinking about a number of issues which confront them.' -- John W. Medcof, R&D Management 'Based on a broad theoretical foundation and broad empirical evidence gathered with different methodologies and tools, it provides many insights into the state of biotechnology in Europe and many suggestions for political measures. Viewed as a whole, this book is rewarding reading for researchers, management practitioners and policymakers.' -- Andre Jungmittag, Research Policy 'The book gives lots of interesting information on venture capital biotechnology companies...' -- Parvinder Chawla, Journal of Scientific and Industrial Research
Author Information
Edited by Jacqueline Senker, Senior Fellow, formerly SPRU – Science and Technology Policy Research, University of Sussex, UK
